国家医疗保障局与人力资源社会保障部联合发布了2026年版《国家基本医疗保险、生育保险和工伤保险药品目录》及《商业健康保险创新药品目录》1。此次调整是国家医保局成立以来连续第9次对国家基本医保药品目录进行更新,新版基本医保目录新增107种药品,其中包含51个1类创新药,调整后药品总数达到3331个1。同时,《商业健康保险创新药品目录》新增了12个创新药物,使涵盖的药品数量增加至28个,旨在通过打通商保创新药目录与基本医保的衔接机制,重点纳入临床获益明确的创新药,进一步提升用药可及性并减轻患者负担1。
新版的实施将建立在既往政策成效的基础上,此前纳入首版商保创新药目录的药品已取得显著进展1。截至今年10月底,去年纳入首版商保创新药目录的药品已在1710家医疗机构及定点零售药店配备,累计服务用药人次近3万人,拉动药品销售约6亿元1。数据显示,相较于纳入目录前,配备机构的数量增长了约140%,单月销售额增长了70%1。新版目录将于2027年1月1日起正式实施1。
The National Healthcare Security Administration and the Ministry of Human Resources and Social Security have jointly released the 2026 editions of the National Basic Medical Insurance, Maternity Insurance, and Work-related Injury Insurance Drug List, along with the Commercial Health Insurance Innovative Drug List 1. This adjustment marks the ninth consecutive update to the basic medical insurance drug catalogue since the establishment of the National Healthcare Security Administration 1. The new version adds 107 drugs to the basic medical insurance list, including 51 Class 1 innovative drugs, bringing the total number of covered medications to 3,331 1.
A key focus of this revision is the inclusion of innovative drugs with clear clinical benefits and the creation of a linkage mechanism between the commercial health insurance innovative drug catalogue and basic medical insurance 1. The 2026 Commercial Health Insurance Innovative Drug List has added 12 new innovative drugs, expanding its coverage to a total of 28 medications 1. These changes are designed to improve drug accessibility for patients and alleviate their financial burdens 1.
Data from previous years indicates growing uptake of commercially insured innovative drugs. By the end of October this year, drugs included in the first edition of the commercial health insurance innovative drug catalogue last year were available at 1,710 medical institutions and designated retail pharmacies 1. Cumulative usage by nearly 30,000 patient instances has been recorded, generating approximately 600 million yuan in drug sales 1. Compared to the period before these drugs were catalogued, the number of facilities stocking them increased by roughly 140%, while monthly sales revenue rose by 70% 1. The newly updated catalogues will officially take effect on January 1, 2027 1.
评论
还没有评论,欢迎留下第一条。